EcoDrugPlus

Glutamate Receptor 2-Like

Ensembl ID : ENSAMXG00000015643
Gene Symbol: LOC103028119
3 Cross references
244 Possible Orthologues:

Glutamate Receptor 4

Ensembl ID : ENSAMXG00000002917
Gene Symbol: LOC103035012
3 Cross references
252 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSAMXG00000009395
Gene Symbol: LOC103040794
2 Cross references
215 Possible Orthologues:

Glutamate Receptor Ionotropic, Kainate 2-Like

Ensembl ID : ENSAMXG00000004419
Gene Symbol: LOC103044887
2 Cross references
252 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2b

Ensembl ID : ENSAMXG00000031292
Gene Symbol: GRIA2B
1 Cross references
256 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1a

Ensembl ID : ENSAMXG00000030727
Gene Symbol: GRIN1A
1 Cross references
205 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1b

Ensembl ID : ENSAMXG00000016090
Gene Symbol: GRIN1B
1 Cross references
152 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSAMXG00000018685
Gene Symbol: GRIN2BB
1 Cross references
256 Possible Orthologues:

Glutaminase

Ensembl ID : ENSAMXG00000018557
Gene Symbol: GLS
3 Cross references
174 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSAMXG00000013859
Gene Symbol: LOC103029175
3 Cross references
230 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSAMXG00000040878
Gene Symbol: LOC111196897
2 Cross references
160 Possible Orthologues:

Glutathione S-Transferase Pi 1

Ensembl ID : ENSAMXG00000039650
Gene Symbol: GSTP1
4 Cross references
161 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).